Target intelligence / Profile preview

Collagen-related processes

Molecular classification
Other
01

Overview

Collagen-related processes encompass the multi-step biochemical pathways responsible for the synthesis, maturation, and turnover of collagen, the most abundant protein in the human body (Source: StatPearls, Collagen Synthesis). These processes involve intracellular steps like pro-alpha chain synthesis and hydroxylation, followed by extracellular assembly and cross-linking by enzymes such as lysyl oxidase (Source: UniProt). In pathological states, an imbalance in these processes leads to excessive deposition (fibrosis) or insufficient structural integrity, as seen in Osteogenesis imperfecta or Ehlers-Danlos syndrome (Source: PubMed, PMID: 28215447). Drugs targeting these processes often focus on specific components, such as nintedanib for pulmonary fibrosis or collagenase for Dupuytren's contracture (Source: PubChem). Because this term describes a broad set of biological activities rather than a single protein, it is classified as a biological process rather than a specific therapeutic target. Understanding these processes is crucial for developing therapies for wound healing, aging, and fibrotic diseases (Source: NIH).

Other names
Collagen metabolismCollagen synthesis and degradationExtracellular matrix remodelingCollagen turnover
02

Mechanism of action

Modulation of collagen synthesis, post-translational modification, cross-linking, or enzymatic degradation to restore extracellular matrix homeostasis.

03

Biological functions

Extracellular matrix organizationWound healingCell adhesionTissue remodelingStructural support
04

Disease associations

FibrosisOsteogenesis imperfectaEhlers-Danlos syndromeSclerodermaCancer metastasisScurvy
05

Safety considerations

Impaired wound healingTissue fragilitySystemic connective tissue atrophyOff-target effects on healthy extracellular matrix
06

Interacting drugs

Pirfenidone

4 more in the full profile.

07

Biomarkers

Pro-collagen type I N-terminal propeptide (PINP)C-terminal telopeptide of type I collagen (CTX-I)HydroxyprolinePro-collagen type III N-terminal propeptide (PIIINP)

Beyond the preview

Go deeper on Collagen-related processes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Collagen-related processes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call